Beta Bionics, Inc. — Director's Dealing 2025

Feb 4, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Beta Bionics, Inc. (BBNX)
CIK: 0001674632
Period of Report: 2025-01-31

Reporting Person: CARNEY SEAN (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-01-31	Director Stock Option (right to buy)	$7.51	A	55837	Acquired	2030-05-14	Common Stock (55837)	Direct
2025-01-31	Director Stock Option (right to buy)	$7.51	A	30456	Acquired	2032-07-26	Common Stock (30456)	Direct

Footnotes

F1: The shares subject to this option shall vest in 36 equal monthly installments measured from February 12, 2020.

F2: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.

F3: The shares subject to this option shall vest in 36 equal monthly installments measured from July 27, 2022.